奥扎格雷钠治疗肺心病急性加重期高凝状态的临床观察

Clinical Observation of Ozagrel in the Treatment of Pulmonary Heart Disease With Hypercoagulability in Acute Exacerbation

目的对患肺心病急性加重期高凝状态患者使用奥扎格雷钠治疗效果进行分析研究,探讨改善肺心病肺功能的治疗方法。方法根据我院接收的2012年1月~2014年12月的102例肺心病急性发作期患者进行研究分析,将这些患者分为对照组和治疗组,对照采取常规治疗,治疗组采取常规治疗和奥扎雷格治疗,对两组患者的住院时间,以及各项检测指标进行测定,对比患者的指标变化情况。结果治疗组患者的各项指标对比对照组有所下降,两组的血浆凝血酶原时间无变化。结论慢性肺源性心脏病患者接受低分子肝素治疗后,其血液高凝状态会有所改善,患者的住院时间有所缩减,对患者的肺功能有改善。

Objective Patients of pulmonary heart disease with acute exacerbation of hypercoagulable state used ozagrel sodium,and the treatment effect were analyzed,then to explore treatment methods for the improvement of lung function in chronic pulmonary heart disease.Methods According to received 102 cases of pulmonary heart disease with acute exacerbation from January 2012 to December 2014,the patients were divided into control group and treatment group. The control group received conventional treatment,treatment group with conventional treatment and Ozagrel treatment. The two groups of patients,and the detection index were measured,and compared with the changes of patients.Results The indexes of the treatment group were compared with the control group,the plasma prothrombin time in the two groups had no change.Conclusion After treatment with low molecular weight heparin in patients with chronic pulmonary heart disease,the high blood coagulation state can be improved, the length of hospital stay has been reduced,and the lung function of the patients has been improved.